-
Why the FDA May Reverse Course on Avastin
Douglas R. Clifford / St. Petersburg Times-ZUMA Press
If the summer of 2009 was the season of “death panels,” as the debate over health-care reform...
-
blog
Harry Smith’s CBS Colonoscopy: Both Too Much and Too Little Information
MORE
-
blog
Mammograms, Pap Smears, and the PSA: How Other Screening Tests Measure Up
MORE
-
article
Why a Top Cancer Center Could Save Your Life
MORE
-
blog
Cancertainment Revisited: Writer Iva Skoch on NPR's Fresh Air
MORE
-
article
Real Funny People: Young Patients Laugh at Cancer
MORE
-
article
Rethinking the War on Cancer
MORE
-
article
Ornish: Why Atkins Still Doesn't Beat Low-Fat Diet
MORE
-
article
A Deadly Disparity: Blacks, Whites and Cancer
MORE
-
article
The Doctor Factor: Battling Cancer Together
MORE
-
article
Health: Your Lifestyle, Your Genes and Cancer
MORE



